Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you ...
ESTERO, FL / ACCESS Newswire / December 4, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...
The United States Patent and Trademark Office (“USPTO” or the “Office”) released several memoranda[1] the week of December 1, 2025, providing ...
On November 18, 2025, the U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”) issued a precedential decision in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback